| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | 212,817 | 182,307 | 147,897* | 154,211 |
| Cost of revenue | 28,868 | 28,074 | 15,618* | 28,012 |
| Gross profit | 183,949 | 154,233 | 132,279* | 126,199 |
| Research and development | 34,057 | 30,338 | -99,687* | 31,921 |
| Sales and marketing | 81,408 | 68,802 | 829* | 63,520 |
| General and administrative | 28,044 | 23,024 | -102,572* | 36,851 |
| Total operating expenses | 143,509 | 122,164 | -201,431* | 132,292 |
| Income (gain) from operations | 40,440 | 32,069 | 333,710* | -6,093 |
| Other income, net | 3,990 | 3,873 | 5,385* | 4,455 |
| Net income (gain) before income taxes | 44,430 | 35,942 | 339,094* | -1,638 |
| Provision for (benefit from) income taxes | 740 | 814 | 1,178* | 206 |
| Net income (gain) | 43,690 | 35,128 | 337,916* | -1,844 |
| Adjustment to reflect deemed contribution from series d and series e redeemable convertible preferred stock extinguishment | 0 | 0 | - | 0 |
| Unrealized gain (loss) on marketable securities, net of taxes | - | - | -22* | - |
| Income allocated to participating securities | 588 | 1,117 | - | 0 |
| Comprehensive loss | - | - | 337,894 | - |
| Net income (loss) attributable to common stockholders | 43,102 | 34,011 | - | -1,844 |
| Basic EPS | 0.55 | 0.43 | 6.191 | -0.02 |
| Diluted EPS | 0.52 | 0.41 | 6.191 | -0.02 |
| Basic Average Shares | 78,969,000 | 78,619,000 | 54,577,000* | 78,858,000 |
| Diluted Average Shares | 83,424,000 | 82,394,000 | 54,577,000* | 78,858,000 |
Hinge Health, Inc. (HNGE)
Hinge Health, Inc. (HNGE)